Technical Analysis for KNTE - Kinnate Biopharma Inc.

Grade Last Price % Change Price Change
F 28.265 -5.75% -1.73
KNTE closed down 4.94 percent on Monday, April 12, 2021, on 49 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical KNTE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -5.75%
1,2,3 Retracement Bearish Bearish Swing Setup -5.75%
180 Bearish Setup Bearish Swing Setup -5.75%
Boomer Sell Setup Bearish Swing Setup -5.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.75%
Multiple of Ten Bearish Other -5.75%
Inside Day Range Contraction -5.75%
Wide Bands Range Expansion -5.75%
20 DMA Resistance Bearish -10.41%
Multiple of Ten Bullish Other -10.41%
Older End-of-Day Signals for KNTE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 4 hours ago
Down 3% about 4 hours ago
60 Minute Opening Range Breakdown about 5 hours ago
Down 2 % about 5 hours ago
10 DMA Resistance about 5 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors for treating genomically defined cancers. The company's lead product candidate is KIN002787, which is a rapidly accelerated fibrosarcoma inhibitor that is in preclinical stage for the treatment of patients with lung cancer, melanoma, and other solid tumors. Its other products in preclinical stage include KIN003, which are small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors (FGFR)2 and FGFR3 genes; and small molecule research programs, including a Cyclin-Dependent Kinase 12 inhibitor in its KIN004 program. Kinnate Biopharma Inc. was founded in 2018 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Melanoma Sarcoma Lung Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor

Is KNTE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.75
52 Week Low 24.1406
Average Volume 230,166
200-Day Moving Average 0.00
50-Day Moving Average 33.30
20-Day Moving Average 31.44
10-Day Moving Average 30.17
Average True Range 2.74
ADX 38.92
+DI 10.72
-DI 23.50
Chandelier Exit (Long, 3 ATRs ) 29.68
Chandelier Exit (Short, 3 ATRs ) 34.38
Upper Bollinger Band 37.15
Lower Bollinger Band 25.74
Percent B (%b) 0.37
BandWidth 36.29
MACD Line -0.98
MACD Signal Line -1.13
MACD Histogram 0.1508
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.06
Resistance 3 (R3) 33.34 32.60 32.55
Resistance 2 (R2) 32.60 31.82 32.46 32.38
Resistance 1 (R1) 31.29 31.33 30.92 31.01 32.21
Pivot Point 30.55 30.55 30.37 30.41 30.55
Support 1 (S1) 29.25 29.77 28.88 28.97 27.77
Support 2 (S2) 28.51 29.29 28.37 27.60
Support 3 (S3) 27.20 28.51 27.43
Support 4 (S4) 26.92